One company that fits the bill flawlessly is animal health juggernaut Zoetis (ZTS -0.03%) and its vast suite of medicines, vaccines, diagnostics, and more. Let's explore why history suggests that Zoetis is primed to continue its market-beating ways. With 15 of its products each earning more than $100 million in annual sales, Zoetis is a well-diversified enterprise. Better yet, its top-10 products only account for roughly 49% of the company's total sales.
Source: Motley Fool
Related Articles:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.